| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 50.83B | 51.62B | 47.75B | 33.55B | 25.12B |
| Gross Profit | 29.14B | 26.23B | 25.38B | 25.02B | 21.95B |
| EBITDA | 10.89B | 9.81B | 8.34B | 8.73B | 9.87B |
| Net Income | 7.17B | 6.31B | 5.26B | 5.93B | 7.01B |
Balance Sheet | |||||
| Total Assets | 1.54T | 1.52T | 1.48T | 1.51T | 1.38T |
| Cash, Cash Equivalents and Short-Term Investments | 407.56B | 509.67B | 538.31B | 542.42B | 521.33B |
| Total Debt | 219.94B | 185.75B | 176.55B | 183.37B | 166.59B |
| Total Liabilities | 1.47T | 1.45T | 1.41T | 1.44T | 1.31T |
| Stockholders Equity | 77.78B | 71.82B | 71.20B | 68.29B | 69.05B |
Cash Flow | |||||
| Free Cash Flow | 16.88B | 5.54B | -2.65B | 28.48B | 47.20B |
| Operating Cash Flow | 18.74B | 7.11B | -927.00M | 30.23B | 48.92B |
| Investing Cash Flow | 1.59B | -17.89B | -23.41B | -21.67B | 4.27B |
| Financing Cash Flow | 2.26B | 784.00M | -1.39B | 696.00M | 107.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £249.40B | 15.64 | 12.07% | 4.27% | -10.53% | 7.24% | |
70 Outperform | £69.64B | 11.54 | 9.46% | 1.50% | 7.44% | 15.64% | |
69 Neutral | £45.08B | 13.08 | 10.34% | 1.70% | -13.41% | 33.11% | |
68 Neutral | £11.66B | 8.23 | 13.48% | 6.78% | -3.55% | 4.97% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £63.56B | 14.07 | 10.75% | 3.41% | -18.98% | 23.57% | |
60 Neutral | £52.77B | 7.30 | 14.55% | 3.85% | 2.05% | 20.10% |